Tags

Type your tag names separated by a space and hit enter

Liquid chromatography-tandem mass spectrometry analysis of delamanid and its metabolite in human cerebrospinal fluid using protein precipitation and on-line solid-phase extraction.
J Pharm Biomed Anal. 2023 Apr 01; 227:115281.JP

Abstract

The penetration of the antituberculosis drug delamanid into the central nervous system is not established. The distribution of delamanid and its major metabolite, DM-6705, into the cerebrospinal fluid requires investigation. A liquid chromatography-tandem mass spectrometry method for the quantification of delamanid and DM-6705 in human cerebrospinal fluid was developed and validated. The calibration range for both analytes was 0.300 - 30.0 ng/mL. The deuterium-labelled analogue of delamanid (delamanid-d4) and OPC-14714 were used as internal standards for delamanid and DM-6705, respectively. Samples were processed by protein precipitation followed by on-line solid-phase extraction and high-performance liquid chromatography on an Agilent 1260 HPLC system. A Phenomenex Gemini-NX C18 (5.0 µm, 50 mm × 2.0 mm) analytical column was used for on-line solid-phase extraction, and a Waters Xterra MS C18 (5.0 µm, 100 mm × 2.1 mm) analytical column for chromatographic separation using gradient elution, at a flow rate of 300 µL/min. The total run time was 7.5 min. Analytes were detected by multiple reaction monitoring on an AB Sciex 5500 triple quadrupole mass spectrometer at unit mass resolution, with electrospray ionization in the positive mode. Accuracy and precision were assessed over three independent validation batches. Extraction recoveries were more than 98% and were consistent across the analytical range. Both analytes in CSF exhibited non-specific adsorption to polypropylene tubes. The method was used to analyse cerebrospinal fluid samples from patients with pulmonary tuberculosis in an exploratory pharmacokinetic study.

Authors+Show Affiliations

Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.Vanderbilt University Medical Center, Nashville, TN, USA.TASK Applied Science, Cape Town, South Africa.Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa. Electronic address: lubbe.wiesner@uct.ac.za.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

36739721

Citation

Mazanhanga, Marian T., et al. "Liquid Chromatography-tandem Mass Spectrometry Analysis of Delamanid and Its Metabolite in Human Cerebrospinal Fluid Using Protein Precipitation and On-line Solid-phase Extraction." Journal of Pharmaceutical and Biomedical Analysis, vol. 227, 2023, p. 115281.
Mazanhanga MT, Joubert A, Castel SA, et al. Liquid chromatography-tandem mass spectrometry analysis of delamanid and its metabolite in human cerebrospinal fluid using protein precipitation and on-line solid-phase extraction. J Pharm Biomed Anal. 2023;227:115281.
Mazanhanga, M. T., Joubert, A., Castel, S. A., van der Merwe, M., Maartens, G., Dooley, K. E., Upton, C. M., & Wiesner, L. (2023). Liquid chromatography-tandem mass spectrometry analysis of delamanid and its metabolite in human cerebrospinal fluid using protein precipitation and on-line solid-phase extraction. Journal of Pharmaceutical and Biomedical Analysis, 227, 115281. https://doi.org/10.1016/j.jpba.2023.115281
Mazanhanga MT, et al. Liquid Chromatography-tandem Mass Spectrometry Analysis of Delamanid and Its Metabolite in Human Cerebrospinal Fluid Using Protein Precipitation and On-line Solid-phase Extraction. J Pharm Biomed Anal. 2023 Apr 1;227:115281. PubMed PMID: 36739721.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Liquid chromatography-tandem mass spectrometry analysis of delamanid and its metabolite in human cerebrospinal fluid using protein precipitation and on-line solid-phase extraction. AU - Mazanhanga,Marian T, AU - Joubert,Anton, AU - Castel,Sandra A, AU - van der Merwe,Marthinus, AU - Maartens,Gary, AU - Dooley,Kelly E, AU - Upton,Caryn M, AU - Wiesner,Lubbe, Y1 - 2023/02/03/ PY - 2022/12/19/received PY - 2023/01/30/revised PY - 2023/02/01/accepted PY - 2024/04/01/pmc-release PY - 2023/2/6/pubmed PY - 2023/2/6/medline PY - 2023/2/5/entrez KW - Cerebrospinal fluid (CSF) KW - DM-6705 KW - Delamanid KW - Drug-resistant tuberculosis (DR-TB) KW - LC-MS/MS KW - On-line solid-phase extraction (SPE) SP - 115281 EP - 115281 JF - Journal of pharmaceutical and biomedical analysis JO - J Pharm Biomed Anal VL - 227 N2 - The penetration of the antituberculosis drug delamanid into the central nervous system is not established. The distribution of delamanid and its major metabolite, DM-6705, into the cerebrospinal fluid requires investigation. A liquid chromatography-tandem mass spectrometry method for the quantification of delamanid and DM-6705 in human cerebrospinal fluid was developed and validated. The calibration range for both analytes was 0.300 - 30.0 ng/mL. The deuterium-labelled analogue of delamanid (delamanid-d4) and OPC-14714 were used as internal standards for delamanid and DM-6705, respectively. Samples were processed by protein precipitation followed by on-line solid-phase extraction and high-performance liquid chromatography on an Agilent 1260 HPLC system. A Phenomenex Gemini-NX C18 (5.0 µm, 50 mm × 2.0 mm) analytical column was used for on-line solid-phase extraction, and a Waters Xterra MS C18 (5.0 µm, 100 mm × 2.1 mm) analytical column for chromatographic separation using gradient elution, at a flow rate of 300 µL/min. The total run time was 7.5 min. Analytes were detected by multiple reaction monitoring on an AB Sciex 5500 triple quadrupole mass spectrometer at unit mass resolution, with electrospray ionization in the positive mode. Accuracy and precision were assessed over three independent validation batches. Extraction recoveries were more than 98% and were consistent across the analytical range. Both analytes in CSF exhibited non-specific adsorption to polypropylene tubes. The method was used to analyse cerebrospinal fluid samples from patients with pulmonary tuberculosis in an exploratory pharmacokinetic study. SN - 1873-264X UR - https://www.unboundmedicine.com/medline/citation/36739721/Liquid_chromatography_tandem_mass_spectrometry_analysis_of_delamanid_and_its_metabolite_in_human_cerebrospinal_fluid_using_protein_precipitation_and_on_line_solid_phase_extraction_ DB - PRIME DP - Unbound Medicine ER -